Global Biochemical Befense Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 112 pages | ID: G1D45206CF8EEN
GlobalInfoResearch

Abstracts

The Biochemical Befense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biochemical Befense market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation

Biochemical Befense market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Anthrax
• Smallpox
• Botulism
• Radiation/Nuclear
• Other

Market segment by Application, can be divided into

• National Defense
• Military

Market segment by players, this report covers

• Emergent Biosolutions
• Hytest
• GSK
• Sanofi
• PharmAthene
• Bavarian Nordic
• SIGA Technologies
• Arbutus Biopharma
• DynPort Vaccine
• Xoma Corporation
• Ichor Medical Systems
• Aeolus Pharmaceuticals
• Achaogen
• Elusys Therapeutics
• Dynavax Technologies
• Cleveland BioLabs
• Soligenix
• Alnylam Pharmaceuticals

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Biochemical Befense product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biochemical Befense, with recent developments and future plans

Chapter 3, the Biochemical Befense competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Biochemical Befense market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Biochemical Befense research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Biochemical Befense
1.2 Classification of Biochemical Befense by Type
  1.2.1 Overview: Global Biochemical Befense Market Size by Type: 2022 Versus 2028
  1.2.2 Global Biochemical Befense Revenue Market Share by Type in 2029
  1.2.3 Anthrax
  1.2.4 Smallpox
  1.2.5 Botulism
  1.2.6 Radiation/Nuclear
  1.2.7 Other
1.3 Global Biochemical Befense Market by Application
  1.3.1 Overview: Global Biochemical Befense Market Size by Application: 2023 Versus 2029
  1.3.2 National Defense
  1.3.3 Military
1.4 Global Biochemical Befense Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Biochemical Befense Market Drivers
  1.5.2 Biochemical Befense Market Restraints
  1.5.3 Biochemical Befense Trends Analysis

2 COMPANY PROFILES

2.1 Emergent Biosolutions
  2.1.1 Emergent Biosolutions Details
  2.1.2 Emergent Biosolutions Major Business
  2.1.3 Emergent Biosolutions Biochemical Befense Product and Solutions
  2.1.4 Emergent Biosolutions Recent Developments and Future Plans
2.2 Hytest
  2.2.1 Hytest Details
  2.2.2 Hytest Major Business
  2.2.3 Hytest Biochemical Befense Product and Solutions
  2.2.4 Hytest Recent Developments and Future Plans
2.3 GSK
  2.3.1 GSK Details
  2.3.2 GSK Major Business
  2.3.3 GSK Biochemical Befense Product and Solutions
  2.3.4 GSK Recent Developments and Future Plans
2.4 Sanofi
  2.4.1 Sanofi Details
  2.4.2 Sanofi Major Business
  2.4.3 Sanofi Biochemical Befense Product and Solutions
  2.4.4 Sanofi Recent Developments and Future Plans
2.5 PharmAthene
  2.5.1 PharmAthene Details
  2.5.2 PharmAthene Major Business
  2.5.3 PharmAthene Biochemical Befense Product and Solutions
  2.5.4 PharmAthene Recent Developments and Future Plans
2.6 Bavarian Nordic
  2.6.1 Bavarian Nordic Details
  2.6.2 Bavarian Nordic Major Business
  2.6.3 Bavarian Nordic Biochemical Befense Product and Solutions
  2.6.4 Bavarian Nordic Recent Developments and Future Plans
2.7 SIGA Technologies
  2.7.1 SIGA Technologies Details
  2.7.2 SIGA Technologies Major Business
  2.7.3 SIGA Technologies Biochemical Befense Product and Solutions
  2.7.4 SIGA Technologies Recent Developments and Future Plans
2.8 Arbutus Biopharma
  2.8.1 Arbutus Biopharma Details
  2.8.2 Arbutus Biopharma Major Business
  2.8.3 Arbutus Biopharma Biochemical Befense Product and Solutions
  2.8.4 Arbutus Biopharma Recent Developments and Future Plans
2.9 DynPort Vaccine
  2.9.1 DynPort Vaccine Details
  2.9.2 DynPort Vaccine Major Business
  2.9.3 DynPort Vaccine Biochemical Befense Product and Solutions
  2.9.4 DynPort Vaccine Recent Developments and Future Plans
2.10 Xoma Corporation
  2.10.1 Xoma Corporation Details
  2.10.2 Xoma Corporation Major Business
  2.10.3 Xoma Corporation Biochemical Befense Product and Solutions
  2.10.4 Xoma Corporation Recent Developments and Future Plans
2.11 Ichor Medical Systems
  2.11.1 Ichor Medical Systems Details
  2.11.2 Ichor Medical Systems Major Business
  2.11.3 Ichor Medical Systems Biochemical Befense Product and Solutions
  2.11.4 Ichor Medical Systems Recent Developments and Future Plans
2.12 Aeolus Pharmaceuticals
  2.12.1 Aeolus Pharmaceuticals Details
  2.12.2 Aeolus Pharmaceuticals Major Business
  2.12.3 Aeolus Pharmaceuticals Biochemical Befense Product and Solutions
  2.12.4 Aeolus Pharmaceuticals Recent Developments and Future Plans
2.13 Achaogen
  2.13.1 Achaogen Details
  2.13.2 Achaogen Major Business
  2.13.3 Achaogen Biochemical Befense Product and Solutions
  2.13.4 Achaogen Recent Developments and Future Plans
2.14 Elusys Therapeutics
  2.14.1 Elusys Therapeutics Details
  2.14.2 Elusys Therapeutics Major Business
  2.14.3 Elusys Therapeutics Biochemical Befense Product and Solutions
  2.14.4 Elusys Therapeutics Recent Developments and Future Plans
2.15 Dynavax Technologies
  2.15.1 Dynavax Technologies Details
  2.15.2 Dynavax Technologies Major Business
  2.15.3 Dynavax Technologies Biochemical Befense Product and Solutions
  2.15.4 Dynavax Technologies Recent Developments and Future Plans
2.16 Cleveland BioLabs
  2.16.1 Cleveland BioLabs Details
  2.16.2 Cleveland BioLabs Major Business
  2.16.3 Cleveland BioLabs Biochemical Befense Product and Solutions
  2.16.4 Cleveland BioLabs Recent Developments and Future Plans
2.17 Soligenix
  2.17.1 Soligenix Details
  2.17.2 Soligenix Major Business
  2.17.3 Soligenix Biochemical Befense Product and Solutions
  2.17.4 Soligenix Recent Developments and Future Plans
2.18 Alnylam Pharmaceuticals
  2.18.1 Alnylam Pharmaceuticals Details
  2.18.2 Alnylam Pharmaceuticals Major Business
  2.18.3 Alnylam Pharmaceuticals Biochemical Befense Product and Solutions
  2.18.4 Alnylam Pharmaceuticals Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Biochemical Befense Revenue and Share by Players (2023 & 2029)
3.2 Biochemical Befense Players Head Office, Products and Services Provided
3.3 Biochemical Befense Mergers & Acquisitions
3.4 Biochemical Befense New Entrants and Expansion Plans

4 GLOBAL BIOCHEMICAL BEFENSE FORECAST BY REGION

4.1 Global Biochemical Befense Market Size by Region: 2023 VS 2029
4.2 Global Biochemical Befense Market Size by Region, (2023-2029)
4.3 North America
  4.3.1 Key Companies of Biochemical Befense in North America
  4.3.2 Current Situation and Forecast of Biochemical Befense in North America
  4.3.3 North America Biochemical Befense Market Size and Prospect (2023-2029)
4.4 Europe
  4.4.1 Key Companies of Biochemical Befense in Europe
  4.4.2 Current Situation and Forecast of Biochemical Befense in Europe
  4.4.3 Europe Biochemical Befense Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
  4.5.1 Key Companies of Biochemical Befense in Asia-Pacific
  4.5.2 Current Situation and Forecast of Biochemical Befense in Asia-Pacific
  4.5.3 Asia-Pacific Biochemical Befense Market Size and Prospect (2023-2029)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Biochemical Befense in South America
  4.6.2 Current Situation and Forecast of Biochemical Befense in South America
  4.6.3 South America Biochemical Befense Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
  4.7.1 Key Companies of Biochemical Befense in Middle East & Africa
  4.7.2 Current Situation and Forecast of Biochemical Befense in Middle East & Africa
  4.7.3 Middle East & Africa Biochemical Befense Market Size and Prospect (2023-2029)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Biochemical Befense Market Forecast by Type (2023-2029)
5.2 Global Biochemical Befense Market Share Forecast by Type (2023-2029)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Biochemical Befense Market Forecast by Application (2023-2029)
6.2 Global Biochemical Befense Market Share Forecast by Application (2023-2029)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Biochemical Befense Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Biochemical Befense Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Emergent Biosolutions Corporate Information, Head Office, and Major Competitors
Table 4. Emergent Biosolutions Major Business
Table 5. Emergent Biosolutions Biochemical Befense Product and Solutions
Table 6. Hytest Corporate Information, Head Office, and Major Competitors
Table 7. Hytest Major Business
Table 8. Hytest Biochemical Befense Product and Solutions
Table 9. GSK Corporate Information, Head Office, and Major Competitors
Table 10. GSK Major Business
Table 11. GSK Biochemical Befense Product and Solutions
Table 12. Sanofi Corporate Information, Head Office, and Major Competitors
Table 13. Sanofi Major Business
Table 14. Sanofi Biochemical Befense Product and Solutions
Table 15. PharmAthene Corporate Information, Head Office, and Major Competitors
Table 16. PharmAthene Major Business
Table 17. PharmAthene Biochemical Befense Product and Solutions
Table 18. Bavarian Nordic Corporate Information, Head Office, and Major Competitors
Table 19. Bavarian Nordic Major Business
Table 20. Bavarian Nordic Biochemical Befense Product and Solutions
Table 21. SIGA Technologies Corporate Information, Head Office, and Major Competitors
Table 22. SIGA Technologies Major Business
Table 23. SIGA Technologies Biochemical Befense Product and Solutions
Table 24. Arbutus Biopharma Corporate Information, Head Office, and Major Competitors
Table 25. Arbutus Biopharma Major Business
Table 26. Arbutus Biopharma Biochemical Befense Product and Solutions
Table 27. DynPort Vaccine Corporate Information, Head Office, and Major Competitors
Table 28. DynPort Vaccine Major Business
Table 29. DynPort Vaccine Biochemical Befense Product and Solutions
Table 30. Xoma Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Xoma Corporation Major Business
Table 32. Xoma Corporation Biochemical Befense Product and Solutions
Table 33. Ichor Medical Systems Corporate Information, Head Office, and Major Competitors
Table 34. Ichor Medical Systems Major Business
Table 35. Ichor Medical Systems Biochemical Befense Product and Solutions
Table 36. Aeolus Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 37. Aeolus Pharmaceuticals Major Business
Table 38. Aeolus Pharmaceuticals Biochemical Befense Product and Solutions
Table 39. Achaogen Corporate Information, Head Office, and Major Competitors
Table 40. Achaogen Major Business
Table 41. Achaogen Biochemical Befense Product and Solutions
Table 42. Elusys Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Elusys Therapeutics Major Business
Table 44. Elusys Therapeutics Biochemical Befense Product and Solutions
Table 45. Dynavax Technologies Corporate Information, Head Office, and Major Competitors
Table 46. Dynavax Technologies Major Business
Table 47. Dynavax Technologies Biochemical Befense Product and Solutions
Table 48. Cleveland BioLabs Corporate Information, Head Office, and Major Competitors
Table 49. Cleveland BioLabs Major Business
Table 50. Cleveland BioLabs Biochemical Befense Product and Solutions
Table 51. Soligenix Corporate Information, Head Office, and Major Competitors
Table 52. Soligenix Major Business
Table 53. Soligenix Biochemical Befense Product and Solutions
Table 54. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. Alnylam Pharmaceuticals Major Business
Table 56. Alnylam Pharmaceuticals Biochemical Befense Product and Solutions
Table 57. Global Biochemical Befense Revenue (USD Million) by Players (2023 & 2029)
Table 58. Global Biochemical Befense Revenue Share by Players (2023 & 2029)
Table 59. Biochemical Befense Players Head Office, Products and Services Provided
Table 60. Biochemical Befense Mergers & Acquisitions in the Past Five Years
Table 61. Biochemical Befense New Entrants and Expansion Plans
Table 62. Global Market Biochemical Befense Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 63. Global Biochemical Befense Revenue Market Share by Region (2023-2029)
Table 64. Key Companies of Biochemical Befense in North America
Table 65. Current Situation and Forecast of Biochemical Befense in North America
Table 66. Key Companies of Biochemical Befense in Europe
Table 67. Current Situation and Forecast of Biochemical Befense in Europe
Table 68. Key Companies of Biochemical Befense in Asia-Pacific
Table 69. Current Situation and Forecast of Biochemical Befense in Asia-Pacific
Table 70. Key Companies of Biochemical Befense in China
Table 71. Key Companies of Biochemical Befense in Japan
Table 72. Key Companies of Biochemical Befense in South Korea
Table 73. Key Companies of Biochemical Befense in South America
Table 74. Current Situation and Forecast of Biochemical Befense in South America
Table 75. Key Companies of Biochemical Befense in Middle East & Africa
Table 76. Current Situation and Forecast of Biochemical Befense in Middle East & Africa
Table 77. Global Biochemical Befense Revenue Forecast by Type (2023-2029)
Table 78. Global Biochemical Befense Revenue Forecast by Application (2023-2029)

List Of Figures

LIST OF FIGURES

Figure 1. Biochemical Befense Picture
Figure 2. Global Biochemical Befense Revenue Market Share by Type in 2029
Figure 3. Anthrax
Figure 4. Smallpox
Figure 5. Botulism
Figure 6. Radiation/Nuclear
Figure 7. Other
Figure 8. Biochemical Befense Revenue Market Share by Application in 2029
Figure 9. National Defense Picture
Figure 10. Military Picture
Figure 11. Global Biochemical Befense Market Size, (USD Million): 2023 VS 2029
Figure 12. Global Biochemical Befense Revenue and Forecast (2023-2029) & (USD Million)
Figure 13. Biochemical Befense Market Drivers
Figure 14. Biochemical Befense Market Restraints
Figure 15. Biochemical Befense Market Trends
Figure 16. Emergent Biosolutions Recent Developments and Future Plans
Figure 17. Hytest Recent Developments and Future Plans
Figure 18. GSK Recent Developments and Future Plans
Figure 19. Sanofi Recent Developments and Future Plans
Figure 20. PharmAthene Recent Developments and Future Plans
Figure 21. Bavarian Nordic Recent Developments and Future Plans
Figure 22. SIGA Technologies Recent Developments and Future Plans
Figure 23. Arbutus Biopharma Recent Developments and Future Plans
Figure 24. DynPort Vaccine Recent Developments and Future Plans
Figure 25. Xoma Corporation Recent Developments and Future Plans
Figure 26. Ichor Medical Systems Recent Developments and Future Plans
Figure 27. Aeolus Pharmaceuticals Recent Developments and Future Plans
Figure 28. Achaogen Recent Developments and Future Plans
Figure 29. Elusys Therapeutics Recent Developments and Future Plans
Figure 30. Dynavax Technologies Recent Developments and Future Plans
Figure 31. Cleveland BioLabs Recent Developments and Future Plans
Figure 32. Soligenix Recent Developments and Future Plans
Figure 33. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 34. Global Biochemical Befense Revenue Market Share by Region (2023-2029)
Figure 35. Global Biochemical Befense Revenue Market Share by Region in 2029
Figure 36. North America Biochemical Befense Revenue (USD Million) and Growth Rate (2023-2029)
Figure 37. Europe Biochemical Befense Revenue (USD Million) and Growth Rate (2023-2029)
Figure 38. Asia-Pacific Biochemical Befense Revenue (USD Million) and Growth Rate (2023-2029)
Figure 39. South America Biochemical Befense Revenue (USD Million) and Growth Rate (2023-2029)
Figure 40. Middle East & Africa Biochemical Befense Revenue (USD Million) and Growth Rate (2023-2029)
Figure 41. Global Biochemical Befense Market Share Forecast by Type (2023-2029)
Figure 42. Global Biochemical Befense Market Share Forecast by Application (2023-2029)
Figure 43. Methodology
Figure 44. Research Process and Data Source